Skyepharma

Developer of small molecule based oral and inhalation products for the treatment of various diseases

placeLondon, England, United Kingdom calendar_todayFounded 1996 groups186 employees language skyepharma.com

Innovation

11 patent families (7 granted) — focus: Human necessities; filing pace dormant. Cited 154 times.

YearFilings
20121

Investor mix

4 investors on record.

Investor typeCountShare
Venture capital125%
Private equity250%
Other / undisclosed125%
Coming soon